TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.30
+0.30 (2.73%)
At close: Dec 5, 2025

TPEX:4157 Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
58.8574.14374.66243.11364.9360.85
Upgrade
Short-Term Investments
696.87751.28598.2591.11495.38197.22
Upgrade
Trading Asset Securities
106.18194.465.1464.3964.0972.7
Upgrade
Cash & Short-Term Investments
861.91,0201,038898.6924.4330.78
Upgrade
Cash Growth
-18.70%-1.75%15.51%-2.79%179.46%-48.12%
Upgrade
Accounts Receivable
3.757.338.9818.41278.287.31
Upgrade
Other Receivables
8.959.0724.885.32.6128.64
Upgrade
Receivables
12.716.433.8723.71280.8935.95
Upgrade
Inventory
53.4742.7134.1515.3517.8814.65
Upgrade
Other Current Assets
15.877.164.3711.578.8410.22
Upgrade
Total Current Assets
943.941,0861,110949.241,232391.6
Upgrade
Property, Plant & Equipment
48.0867.4790.6156.680.4342.47
Upgrade
Long-Term Investments
3.052.459.7123.9853.985.86
Upgrade
Other Intangible Assets
012.0512.990.230.160.29
Upgrade
Other Long-Term Assets
18.316.226.1616.9626.3136.24
Upgrade
Total Assets
1,0131,1741,2301,0471,393556.45
Upgrade
Short-Term Debt
35--3--
Upgrade
Current Portion of Leases
16.5916.3315.9818.3417.9917.12
Upgrade
Current Income Taxes Payable
-0.11-3.0727.86-
Upgrade
Current Unearned Revenue
0.170.150.150.150.1844.41
Upgrade
Other Current Liabilities
35.7629.531.7626.7643.8533.37
Upgrade
Total Current Liabilities
87.5246.0847.8951.3289.8894.91
Upgrade
Long-Term Leases
29.9142.3958.7117.1335.47-
Upgrade
Long-Term Unearned Revenue
0.090.180.330.480.620.79
Upgrade
Pension & Post-Retirement Benefits
3.183.314.018.0513.1518.57
Upgrade
Total Liabilities
120.791.96110.9476.98139.11114.26
Upgrade
Common Stock
20.9420.9420.9420.9120.9120.91
Upgrade
Additional Paid-In Capital
457.84466.3444.61450.26455.25675.14
Upgrade
Retained Earnings
481.06640.6678.68542.05778.3-300.21
Upgrade
Comprehensive Income & Other
-16.68-45.51-25.34-43.2-0.7746.34
Upgrade
Shareholders' Equity
892.681,0821,119970.031,254442.18
Upgrade
Total Liabilities & Equity
1,0131,1741,2301,0471,393556.45
Upgrade
Total Debt
81.558.7174.6938.4753.4617.12
Upgrade
Net Cash (Debt)
780.4961.11963.3860.13870.94313.66
Upgrade
Net Cash Growth
-21.76%-0.23%12.00%-1.24%177.67%-45.10%
Upgrade
Net Cash Per Share
1.091.341.341.201.210.44
Upgrade
Filing Date Shares Outstanding
717.84717.84717.84716.84716.84716.84
Upgrade
Total Common Shares Outstanding
717.84717.84717.84716.84716.84716.84
Upgrade
Working Capital
856.421,0401,062897.921,142296.69
Upgrade
Book Value Per Share
1.241.511.561.351.750.62
Upgrade
Tangible Book Value
892.681,0701,106969.81,254441.89
Upgrade
Tangible Book Value Per Share
1.241.491.541.351.750.62
Upgrade
Machinery
89.28144.93144.38143.76140.92148.2
Upgrade
Leasehold Improvements
1.6760.7960.6660.7160.6758.11
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.